Loginova S Ia, Koval'chuk A V, Borisevich S V, Kopylova N K, Pashchenko Iu I, Khamitov R A, Maksimov V A, Shuster A M
Vopr Virusol. 2005 Nov-Dec;50(6):30-2.
The antiviral effectiveness of the combined and single use of superlow-dose amixine and virasole on the course of experimental hemorrhagic fever with renal syndrome was studied in sucking albino mice parenterally infected with their virus Hantaan. The co-administration of virasole and amixine was shown to protect 52% of the infected animals from death, which is superior to the effect of their monotherapy. The combined use of the drugs substantially prolongs the survival of albino mice after their infection and the level of brain viral reproduction suppression ( delta = 3.21 g) in the experimental group as compared to the controls and to the mice given only one of the drugs.
在经汉坦病毒腹腔注射感染的白化病幼鼠中,研究了超低剂量的安米昔和病毒唑联合及单独使用对实验性肾综合征出血热病程的抗病毒效果。结果显示,病毒唑与安米昔联合使用可使52%的受感染动物免于死亡,这一效果优于单一疗法。与对照组以及仅使用一种药物的小鼠相比,药物联合使用显著延长了白化病小鼠感染后的存活时间,并且实验组中脑内病毒复制抑制水平(δ = 3.21 g)更高。